Home / Stocks / ITOS

ITOS insider trading

iTeos Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
2
Bought · 24 mo
$38.7M
Buys · last 90 days
0 · $0
Most recent buy
2025-05-16

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-05-16EcoR1 Capital, LLC
10% owner
Bought4,958,978$7.80$38.7M
2025-05-15GADICKE ANSBERT
Insider
Sold1,031,931$8.06$8.3M
2025-05-15MPM BIOVENTURES 2018, L.P.
Insider
Sold630,191$8.06$5.1M
2025-05-15EVNIN LUKE
Insider
Sold630,191$8.06$5.1M
2024-11-19Gall Matthew
Chief Financial Officer
Bought5,000$7.73$39k

Most active insider buyers

InsiderRoleBuysTotal bought
EcoR1 Capital, LLC10% owner1$38.7M
Gall MatthewChief Financial Officer1$39k

See ITOS on the chart

Every insider buy and sell for ITOS plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.